Glaukos Price to Book Ratio 2014-2025 | GKOS
Historical price to book ratio values for Glaukos (GKOS) over the last 10 years. The current price to book ratio for Glaukos as of January 15, 2026 is 7.79.
| Glaukos Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-01-15 | 114.48 | 8.54 | |
| 2025-09-30 | 81.55 | $13.41 | 6.08 |
| 2025-06-30 | 103.29 | $13.36 | 7.73 |
| 2025-03-31 | 98.42 | $13.46 | 7.31 |
| 2024-12-31 | 149.94 | $13.59 | 11.04 |
| 2024-09-30 | 130.28 | $12.13 | 10.74 |
| 2024-06-30 | 118.35 | $12.13 | 9.75 |
| 2024-03-31 | 94.29 | $9.04 | 10.43 |
| 2023-12-31 | 79.49 | $9.40 | 8.46 |
| 2023-09-30 | 75.25 | $9.80 | 7.68 |
| 2023-06-30 | 71.21 | $10.10 | 7.05 |
| 2023-03-31 | 50.10 | $10.61 | 4.72 |
| 2022-12-31 | 43.68 | $11.10 | 3.94 |
| 2022-09-30 | 53.24 | $11.51 | 4.63 |
| 2022-06-30 | 45.42 | $11.86 | 3.83 |
| 2022-03-31 | 57.82 | $12.69 | 4.56 |
| 2021-12-31 | 44.44 | $12.50 | 3.55 |
| 2021-09-30 | 48.17 | $12.83 | 3.76 |
| 2021-06-30 | 84.83 | $12.57 | 6.75 |
| 2021-03-31 | 83.93 | $12.82 | 6.54 |
| 2020-12-31 | 75.26 | $14.75 | 5.10 |
| 2020-09-30 | 49.52 | $14.76 | 3.36 |
| 2020-06-30 | 38.42 | $14.87 | 2.58 |
| 2020-03-31 | 30.86 | $14.54 | 2.12 |
| 2019-12-31 | 54.47 | $15.48 | 3.52 |
| 2019-09-30 | 62.51 | $5.15 | 12.14 |
| 2019-06-30 | 75.40 | $5.13 | 14.71 |
| 2019-03-31 | 78.37 | $5.11 | 15.35 |
| 2018-12-31 | 56.17 | $4.82 | 11.67 |
| 2018-09-30 | 64.90 | $4.54 | 14.29 |
| 2018-06-30 | 40.64 | $4.23 | 9.61 |
| 2018-03-31 | 30.83 | $4.11 | 7.51 |
| 2017-12-31 | 25.65 | $3.99 | 6.43 |
| 2017-09-30 | 33.00 | $3.82 | 8.63 |
| 2017-06-30 | 41.47 | $3.66 | 11.34 |
| 2017-03-31 | 51.30 | $3.59 | 14.30 |
| 2016-12-31 | 34.30 | $3.46 | 9.93 |
| 2016-09-30 | 37.74 | $3.31 | 11.41 |
| 2016-06-30 | 29.16 | $3.19 | 9.13 |
| 2016-03-31 | 16.86 | $3.03 | 5.57 |
| 2015-12-31 | 24.69 | $2.96 | 8.35 |
| 2015-09-30 | 24.19 | $2.95 | 8.19 |
| 2015-06-30 | 28.98 | $2.97 | 9.77 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $5.998B | $0.383B |
| Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $233.627B | 27.76 |
| Intuitive Surgical (ISRG) | United States | $196.001B | 76.68 |
| IDEXX Laboratories (IDXX) | United States | $56.733B | 56.34 |
| Edwards Lifesciences (EW) | United States | $48.223B | 32.33 |
| IQVIA Holdings (IQV) | United States | $41.102B | 22.92 |
| Alcon (ALC) | Switzerland | $39.514B | 26.70 |
| Mettler-Toledo (MTD) | United States | $30.348B | 35.51 |
| DexCom (DXCM) | United States | $27.184B | 37.47 |
| STERIS (STE) | Ireland | $25.935B | 26.77 |
| Waters (WAT) | United States | $23.414B | 30.96 |
| Coloplast (CLPBY) | Denmark | $20.103B | 34.31 |
| Hologic (HOLX) | United States | $16.754B | 17.60 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.523B | 0.00 |
| Globus Medical (GMED) | United States | $12.375B | 25.97 |
| Penumbra (PEN) | United States | $12.275B | 86.34 |
| Masimo (MASI) | United States | $7.435B | 23.82 |
| Sysmex ADR (SSMXY) | Japan | $6.351B | 20.18 |
| TransMedics (TMDX) | United States | $4.851B | 57.47 |
| Teleflex (TFX) | United States | $4.554B | 7.26 |
| Veracyte (VCYT) | United States | $3.356B | 38.24 |
| LivaNova (LIVN) | United Kingdom | $3.323B | 17.95 |
| Integer Holdings (ITGR) | United States | $2.968B | 13.93 |
| Elekta AB (EKTAY) | Sweden | $2.412B | 22.57 |
| Alphatec Holdings (ATEC) | United States | $2.369B | 0.00 |
| Artivion (AORT) | United States | $2.013B | 92.39 |
| UFP Technologies (UFPT) | United States | $2.009B | 26.53 |
| Nihon Kohden (NHNKY) | Japan | $1.974B | 17.23 |
| PROCEPT BioRobotics (PRCT) | United States | $1.753B | 0.00 |
| AxoGen (AXGN) | United States | $1.421B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.415B | 0.00 |
| IRadimed (IRMD) | United States | $1.292B | 61.53 |
| OPKO Health (OPK) | United States | $0.998B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.976B | 5.29 |
| Pulse Biosciences (PLSE) | United States | $0.969B | 0.00 |
| SiBone (SIBN) | United States | $0.757B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.748B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.713B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.670B | 38.96 |
| Alpha Tau Medical (DRTS) | Israel | $0.636B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.567B | 0.00 |
| NeuroPace (NPCE) | United States | $0.558B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.551B | 10.99 |
| Mesa Laboratories (MLAB) | United States | $0.479B | 13.22 |
| OrthoPediatrics (KIDS) | United States | $0.462B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.438B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.422B | 0.00 |
| RxSight (RXST) | United States | $0.398B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.367B | 61.06 |
| Sight Sciences (SGHT) | United States | $0.364B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.327B | 2.44 |
| Spectral Diagnostics (EDTXF) | Canada | $0.310B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.197B | 0.00 |
| 908 Devices (MASS) | United States | $0.197B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.186B | 0.00 |
| Inogen (INGN) | United States | $0.176B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.172B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.171B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.163B | 0.00 |
| CVRx (CVRX) | United States | $0.159B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.153B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.151B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.145B | 0.00 |
| Solana (HSDT) | United States | $0.144B | 0.00 |
| LENSAR (LNSR) | United States | $0.142B | 0.00 |
| Neuronetics (STIM) | United States | $0.121B | 0.00 |
| Hyperfine (HYPR) | United States | $0.120B | 0.00 |
| Accuray (ARAY) | United States | $0.095B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.082B | 0.00 |
| DarioHealth (DRIO) | United States | $0.080B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.078B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.068B | 0.00 |
| InspireMD (NSPR) | United States | $0.067B | 0.00 |
| Positron (POSC) | United States | $0.057B | 0.00 |
| Spectral AI (MDAI) | United States | $0.050B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.021B | 0.00 |
| Envoy Medical (COCH) | United States | $0.020B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| ENvue Medical (FEED) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 10.28 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |